- Home
- INKT vs CLPR Comparison
INKT vs CLPR Comparison
Compare INKT & CLPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INKT | CLPR |
|---|---|---|
| Founded | 2017 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.7M | 54.7M |
| IPO Year | 2021 | 2017 |
Fundamental Metrics
Financial Performance| Metric | INKT | CLPR |
|---|---|---|
| Price | $12.04 | $3.66 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $35.00 | N/A |
| AVG Volume (30 Days) | 19.7K | ★ 92.0K |
| Earning Date | 11-14-2025 | 02-13-2026 |
| Dividend Yield | N/A | ★ 10.56% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $154,179,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 5.90 |
| 52 Week Low | $4.56 | $3.31 |
| 52 Week High | $76.00 | $5.16 |
Technical Indicators
Market Signals| Indicator | INKT | CLPR |
|---|---|---|
| Relative Strength Index (RSI) | 50.94 | 55.10 |
| Support Level | $10.88 | $3.52 |
| Resistance Level | $12.31 | $3.88 |
| Average True Range (ATR) | 0.63 | 0.14 |
| MACD | 0.03 | 0.04 |
| Stochastic Oscillator | 63.04 | 64.91 |
Price Performance
Historical ComparisonAbout INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.
About CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.